Radiation-recall dermatitis with the everolimus/exemestane combination ten years after adjuvant whole-breast radiotherapy

Radiother Oncol. 2014 Sep;112(3):449-50. doi: 10.1016/j.radonc.2014.08.030. Epub 2014 Sep 11.

Authors

Georgios Ioannidis¹, Pinelopi Gkogkou², Pandelitsa Charalampous², Maria Diamandi², Rena Ioannou²

Affiliations

¹ Oncology Department, Nicosia General Hospital, 215, Nicosia-Limassol Old Ave., 2029 Strovolos, Nicosia, Cyprus. Electronic address: geoioann71@gmail.com.
² Oncology Department, Nicosia General Hospital, Cyprus.

PMID: 25220368
DOI: 10.1016/j.radonc.2014.08.030

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Androstadienes / adverse effects*
Androstadienes / therapeutic use
Antineoplastic Agents / therapeutic use
Bone Neoplasms / drug therapy*
Bone Neoplasms / secondary
Breast Neoplasms / pathology
Breast Neoplasms / radiotherapy*
Drug Therapy, Combination / methods
Everolimus
Female
Humans
Liver Neoplasms / drug therapy*
Liver Neoplasms / secondary
Middle Aged
Neoplasms, Second Primary / drug therapy
Radiodermatitis / etiology*
Radiotherapy, Adjuvant / methods
Sirolimus / adverse effects
Sirolimus / analogs & derivatives*
Sirolimus / therapeutic use

Substances

Androstadienes
Antineoplastic Agents
Everolimus
exemestane
Sirolimus